AT364095B - Verfahren zur herstellung neuer peptidderivate - Google Patents

Verfahren zur herstellung neuer peptidderivate

Info

Publication number
AT364095B
AT364095B AT0445178A AT445178A AT364095B AT 364095 B AT364095 B AT 364095B AT 0445178 A AT0445178 A AT 0445178A AT 445178 A AT445178 A AT 445178A AT 364095 B AT364095 B AT 364095B
Authority
AT
Austria
Prior art keywords
peptide derivatives
producing new
new peptide
producing
derivatives
Prior art date
Application number
AT0445178A
Other languages
German (de)
English (en)
Other versions
ATA445178A (de
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to AT437880A priority Critical patent/AT398765B/de
Publication of ATA445178A publication Critical patent/ATA445178A/de
Application granted granted Critical
Publication of AT364095B publication Critical patent/AT364095B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT0445178A 1977-06-20 1978-06-19 Verfahren zur herstellung neuer peptidderivate AT364095B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT437880A AT398765B (de) 1977-06-20 1980-08-29 Verfahren zur herstellung von neuen lipopeptiden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77584 1977-06-20

Publications (2)

Publication Number Publication Date
ATA445178A ATA445178A (de) 1981-02-15
AT364095B true AT364095B (de) 1981-09-25

Family

ID=19728618

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0445178A AT364095B (de) 1977-06-20 1978-06-19 Verfahren zur herstellung neuer peptidderivate

Country Status (18)

Country Link
EP (1) EP0000330B1 (xx)
JP (2) JPS549224A (xx)
AT (1) AT364095B (xx)
AU (1) AU525005B2 (xx)
CA (1) CA1139305A (xx)
DD (1) DD139257A5 (xx)
DE (1) DE2860893D1 (xx)
DK (1) DK275178A (xx)
ES (3) ES470961A1 (xx)
FI (1) FI781933A (xx)
GR (1) GR71681B (xx)
IE (1) IE46957B1 (xx)
IL (1) IL54950A (xx)
NO (1) NO148921C (xx)
NZ (1) NZ187611A (xx)
PL (3) PL216740A1 (xx)
PT (1) PT68188A (xx)
ZA (1) ZA783504B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
SG47406A1 (en) * 1991-12-19 1998-04-17 Ciba Geigy Ag Aminosulfonic acid derivatives and processes for their preparation
EP0604945A1 (en) * 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, its derivatives, production and use thereof
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0641776A3 (en) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Thioglycerol derivatives.
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
FR2816060A1 (fr) * 2000-10-27 2002-05-03 Pf Medicament Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules
NZ565063A (en) 2005-06-13 2011-04-29 Cleveland Biolabs Inc Methods of protecting against apoptosis using lipopeptides
MX2008001183A (es) * 2005-07-25 2008-04-11 Therimunex Llc Peptidil diacilgliceridos.
DE102016005550B4 (de) 2016-05-09 2024-09-26 Hans-Georg Rammensee Adjuvans zur lnduzierung einer zellulären lmmunantwort
EP4365125A3 (en) * 2017-11-06 2024-08-21 Crown Equipment Corporation Industrial vehicle layover system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706490A1 (de) 1976-02-20 1977-08-25 Ciba Geigy Ag Neue carbonsaeureester

Also Published As

Publication number Publication date
ES478718A1 (es) 1979-12-16
DK275178A (da) 1978-12-21
DD139257A5 (de) 1979-12-19
NO148921B (no) 1983-10-03
AU525005B2 (en) 1982-10-14
PL207766A1 (pl) 1979-11-19
NO148921C (no) 1984-01-11
JPS641466B2 (xx) 1989-01-11
EP0000330A1 (de) 1979-01-24
IL54950A (en) 1983-10-31
ZA783504B (en) 1979-06-27
FI781933A (fi) 1978-12-21
EP0000330B1 (de) 1981-08-05
ES478717A1 (es) 1979-12-16
NO782138L (no) 1978-12-21
CA1139305A (en) 1983-01-11
NZ187611A (en) 1981-07-13
ATA445178A (de) 1981-02-15
GR71681B (xx) 1983-06-21
JPS549224A (en) 1979-01-24
IE46957B1 (en) 1983-11-16
DE2860893D1 (en) 1981-11-05
IL54950A0 (en) 1978-08-31
ES470961A1 (es) 1980-03-01
PT68188A (de) 1978-07-01
JPS6360760B2 (xx) 1988-11-25
PL216739A1 (xx) 1980-05-19
JPS6372671A (ja) 1988-04-02
PL216740A1 (xx) 1980-05-19
IE781227L (en) 1978-12-20
AU3723078A (en) 1980-01-03

Similar Documents

Publication Publication Date Title
AT359217B (de) Verfahren zur herstellung neuer peptid-derivate
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT364095B (de) Verfahren zur herstellung neuer peptidderivate
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
LU79235A1 (de) Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern
ATA60577A (de) Verfahren zur herstellung neuer polypeptidderivate
AT360553B (de) Verfahren zur herstellung neuer nitroso- harnstoffverbindungen
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
AT363086B (de) Verfahren zur herstellung neuer benzopyranderivate
DD138211A5 (de) Verfahren zur herstellung neuer aminopyrimidin-verbindungen
ATA90478A (de) Verfahren zur herstellung neuer everninomicin- derivate
AT361640B (de) Verfahren zur herstellung neuer 3beta-substi- tuierter 18-beta-olean-9-en-30-oylsaeure- derivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
AT360998B (de) Verfahren zur herstellung neuer n-pyrimidinyl- -imidsaeureester
AT362066B (de) Verfahren zur herstellung neuer spectinomycin- derivate
AT380014B (de) Verfahren zur herstellung neuer oxazolidin-2-on- derivate
DD134765A5 (de) Verfahren zur herstellung neuer indolylglyoxylsaeurederivate
ATA590179A (de) Verfahren zur herstellung neuer 2-aminotetraline
AT373240B (de) Verfahren zur herstellung neuer pyridyloxyphenoxyalkancarbonsaeurederivate
ATA153980A (de) Verfahren zur herstellung neuer 3-oxaloamino-4- oxo-4h-1-benzopyranderivate
ATA269880A (de) Verfahren zur herstellung neuer pyridinderivate
ATA583379A (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
ATA464778A (de) Verfahren zur herstellung neuer indanderivate
AT367767B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate

Legal Events

Date Code Title Description
ELA Expired due to lapse of time